Interscalene Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery
Comparison of the Effectiveness of Interscalene Nerve Block and Serratus Posterior Superior Intercostal Plane Block in Patients Undergoing Arthroscopic Shoulder Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized controlled trial aims to compare the effectiveness of interscalene (ISB) and serratus posterior superior intercostal plane block (SPSIP) for postoperative analgesia in patients undergoing elective arthroscopic shoulder surgery. The primary outcome is total 24-hour opioid consumption. Secondary outcomes include pain scores, hemidiaphragmatic paresis incidence and severity, duration of analgesia, and changes in lung function. Participants are randomized into ISB or SPSIP groups; blocks are performed under ultrasound guidance. Postoperative pain is managed with patient controlled analgesia(PCA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedDecember 30, 2025
December 1, 2025
1 year
December 16, 2025
December 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total 24-Hour Postoperative Opioid Consumption
Total intravenous opioid consumption recorded for each patient during the first 24 hours after arthroscopic shoulder surgery, including any rescue analgesia administered.
0-24 hours postoperatively
Secondary Outcomes (4)
Incidence and Severity of Hemidiaphragmatic Paresis
Pre-block and 30 minutes post-block
Duration of Analgesia
Time interval from block completion to initiation of IV PCA fentanyl in each patient
Pulmonary Function Changes (FEV1)
Pre-block and 30 minutes post-block
Pulmonary Function Changes (FVC)
Pre-block and 30 minutes post-block
Study Arms (2)
Interscalene Brachial Plexus Block (ISB)
EXPERIMENTALPatients will receive ISB under ultrasound guidance prior to arthroscopic shoulder surgery using 15 ml 0.25% bupivacaine.
Serratus Posterior Superior Intercostal Plane Block
EXPERIMENTALPatients will receive SPSIP block under ultrasound guidance using 30 ml 0.25% bupivacaine
Interventions
Patients receive ultrasound-guided ISB before arthroscopic shoulder surgery. 15 ml of 0.25% bupivacaine is injected using a 22 Gauge 50 mm needle with posterior in-plane approach, targeting C5-C6 roots.
Patients receive ultrasound-guided SPSIP interfascial block in sitting position before surgery. Using a 22 Gauge 10 mm needle, 30 ml of 0.25% bupivacaine is injected between serratus posterior muscle and second rib.
Eligibility Criteria
You may qualify if:
- Agreeing to participate in the study
- The American Society of Anesthesiologists I-III
- Scheduled for elective unilateral arthroscopic shoulder surgery
You may not qualify if:
- Refusal to participate in the study
- Allergy to the medications to be used
- History of serious heart, kidney or liver disease
- Neurological deficits or neuropathy
- History of anticoagulant use
- Pre-existing operative respiratory dysfunction
- Having chronic shoulder pain
- Being about to undergo open surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erzurum Regional Training Research Hospital
Erzurum, Yakutiye, 25100, Turkey (Türkiye)
Related Publications (3)
Kumari P, Kumar A, Aliyar R, Sinha L. Continuous serratus posterior superior intercostal plane block for postoperative analgesia in thoracotomy. Anaesth Crit Care Pain Med. 2025 Sep;44(5):101570. doi: 10.1016/j.accpm.2025.101570. Epub 2025 Jun 14. No abstract available.
PMID: 40523524BACKGROUNDDogan G, Kucuk O, Kayir S, Dal GC, Ciftci B, Zengin M, Alagoz A. Serratus posterior superior intercostal plane block versus thoracic paravertebral block for pain management after video-assisted thoracoscopic surgery: a randomized prospective study. Braz J Anesthesiol. 2025 Sep-Oct;75(5):844647. doi: 10.1016/j.bjane.2025.844647. Epub 2025 Jun 3.
PMID: 40473018BACKGROUNDOzen V, Turan EI, Alver S, Ciftci B, Cakir I, Sahin AS. Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in a Pediatric Patient Undergoing Lobectomy: A Case Report. A A Pract. 2025 May 27;19(5):e01988. doi: 10.1213/XAA.0000000000001988. eCollection 2025 May 1.
PMID: 40421887BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ömer Doymus, MD
Erzurum Regional Training & Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The anesthesiologist performing the blocks is aware of the group allocation; all other staff and outcome assessors are blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 16, 2025
First Posted
December 30, 2025
Study Start
December 1, 2024
Primary Completion
December 1, 2025
Study Completion
December 15, 2025
Last Updated
December 30, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share